A practical guide to the Boar's Head listeria lawsuit: the Jarratt, Virginia plant outbreak, the roughly 7-million-pound recall, 10 deaths, the $3.1 million consumer class settlement, and how individual wrongful-death and injury claims work.
A practical 2026 guide to product liability and wrongful death claims after crashes involving Tesla Autopilot or Full Self-Driving, in the wake of 2025 jury verdicts — who may have a claim, product liability vs. driver negligence, EDR vehicle data, deadlines, damages, and how to pick a lawyer.
Invokana (canagliflozin) has been linked to leg and foot amputations and diabetic ketoacidosis (DKA). This guide covers who qualifies for a 2026 lawsuit, MDL 2750 status, how settlement value is calculated, attorney fee structures, and filing deadlines.
A practical 2026 guide to US product liability lawsuits: the three defect theories, strict liability vs. negligence vs. warranty, who you can sue, how settlements are valued, contingency fees, deadlines, and MDL vs. individual suits.
The Ozempic and Wegovy gastroparesis lawsuit doesn't turn on whether you were injured — it turns on the warning label and on whether your stomach paralysis came from the drug or from diabetes. Here is the semaglutide-specific playbook: eligibility, MDL 3094's Novo Nordisk track, objective evidence, settlement value drivers, choosing counsel, and the statute of limitations.
A practical 2026 guide to e-bike accident claims in the US — class 1/2/3 rules, who's liable (rider, driver, or manufacturer), how settlements work, evidence to preserve, and when to hire a lawyer. Informational only, not legal advice.
A plain-English guide to U.S. defective medical device lawsuits — hip and knee implants, hernia mesh, IVC filters, CPAP, breast implants, insulin pumps. Understand 510(k) vs. PMA and the preemption defense, MDL vs. class action, how settlement ranges actually form, the statute of limitations, and how to choose a contingency-fee lawyer.
A practical 2026 guide to product recall insurance cost in the US market. Learn what first-party recall expense covers versus third-party liability, how it differs from product liability insurance, premium and limit ranges by industry and revenue, how underwriting works, and the mistakes that leave manufacturers exposed.
A practical guide to Zepbound (tirzepatide) gastroparesis and bowel obstruction lawsuits — how Eli Lilly's dual GLP-1/GIP agonist differs legally from semaglutide claims, where it sits inside MDL 3094, plaintiff eligibility, settlement ranges, and how to vet an attorney.
What product liability insurance covers, why manufacturers, importers, and distributors need it, occurrence vs claims-made, policy limits, and the 2026 premium cost factors that drive your quote up or down.
If you or a loved one suffered burns, perforations, or other organ injuries during da Vinci robotic surgery, you may have a product-liability claim. Learn about the stray-current defect, the 2013 Urgent Notification, how individual lawsuits work, and what evidence to gather now.
MDL 2666 (D. Minn.) was dismissed after plaintiffs failed Daubert. But state court cases and new federal filings continue. Learn the science, who still has viable claims, and how 3M's Bair Hugger litigation stands in 2026.
MDL 3026 in N.D. Ill. consolidates necrotizing enterocolitis lawsuits against Abbott (Similac) and Mead Johnson (Enfamil). Learn who qualifies, the science behind cow-milk formula and NEC risk, and how trials are proceeding in 2026.
Bard PowerPort catheter fracture, migration, and infection claims in MDL 3081: first bellwether trial started April 2026, 3,384 cases pending, Judge Campbell's critical pre-trial ruling on FDA clearance.
Syngenta and Chevron's confidential settlement framework, MDL 3004 case count at 6,580, Syngenta's production exit, and what agricultural workers with Parkinson's need to know about their claims.
MDL 3043 Daubert dismissal, Second Circuit appeal after November 2025 oral arguments, prenatal acetaminophen science, and how families can evaluate their legal options in 2026.
MDL 3060 has 11,371 plaintiffs — the 3rd-largest MDL in the U.S. NIEHS study (PMID 36245087): frequent users face 2.5x uterine cancer risk. Bellwether trials expected 2027.
MDL 2974: 3,982 cases, first bellwether defense verdict Feb 2026. CooperSurgical and Teva both defendants. Federal preemption is the key legal fight. Eligibility guide.
How MDL 2738 works, why Johnson & Johnson's LTL Management bankruptcy gambit backfired, which ovarian cancer and mesothelioma diagnoses qualify, and the state-by-state statute of limitations traps that catch talc claimants off guard.